Skip to main content
. 2022 Sep 1;12:14887. doi: 10.1038/s41598-022-19315-0

Table 4.

Subgroup analyses stratified by age.

Total femur BMD (gm/cm2) Femoral neck BMD (gm/cm2) Intertrochanter BMD (gm/cm2) L1 BMD (gm/cm2)
50–60 years
Non-aspirin users Reference Reference Reference Reference
Low-dose aspirin users 0.020 (− 0.010, 0.049) P = 0.1907 0.026 (− 0.004, 0.056) P = 0.0931 0.028 (− 0.008, 0.064) P = 0.1289 0.026 (− 0.007, 0.059) P = 0.1190
60–70 years
Non-aspirin users Reference Reference Reference Reference
Low-dose aspirin users 0.037 (0.013, 0.061) P = 0.0024 0.014 (− 0.011, 0.040) P = 0.2614 0.047 (0.018, 0.077) P = 0.0015 0.029 (− 0.004, 0.062) P = 0.0887
70–80 years
Non-aspirin users Reference Reference Reference Reference
Low-dose aspirin users 0.010 (− 0.019, 0.039) P = 0.4979 0.013 (− 0.013, 0.039) P = 0.3352 0.008 (− 0.028, 0.044) P = 0.6663 0.011 (− 0.030, 0.052) P = 0.5989
P interaction P = 0.3347 P = 0.7506 P = 0.2308 P = 0.7528

Gender, Race, Heart attack, Vigorous work activity, BMI, Hba1c, Education level, Ratio of family income to poverty, Fractures, Anti-osteoporotic, Prednisone or Cortisone, HS C-Reactive Protein, Smoking status, Serum Creatinine, Serum Uric acid, Alcohol consumption were adjusted.